Indaptus to commence Phase I trial of solid tumour therapy
The company received FDA clearance for the IND application to initiate the trial.
Oncology
Latest in
Oncology
Cerner, Elligo, Freenome enters partnership to boost cancer clinical trial access
The partnership will allow participation of diverse patients from various demographics and socio-economic factors.
Imugene, City of Hope doses first subject in Phase I solid tumour trial
The trial will assess the safety and tolerability of oncolytic virus CF33-hNIS as monotherapy or along with pembrolizumab.
Calliditas initiates Phase II head and neck cancer therapy trial
The trial will analyse the impact of setanaxib plus pembrolizumab in patients with CAF-density tumours.
Fertility impact questions swirl as breast cancer clinical trials recruit younger patients
Clinical Trials Arena spoke to experts who point to how additional study design parameters can measure and alleviate fertility risk.
By
C4 Therapeutics doses first subject in Phase I/II cancer therapy trial
The trial will analyse the safety, tolerability and anti-tumour activity of CFT8634 for treating SMARCB1-perturbed cancers.
Neoleukin doses first subject in Phase I solid tumour treatment trial
The trial will enrol up to 132 subjects to analyse the efficacy of NL-201 plus Keytruda combination therapy.
Pipeline Moves: Premature Phase II end of cancer, acute pharyngitis clinical trials leads to advancement shot drop
The Clinical Trials Arena team also reviews three separate early-phase trial completions in type 2 diabetes, ophthalmic issues, and cancer.
By